Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1994;14:1021-1031

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rimarachin, J. A.
Right arrow Articles by Weksler, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rimarachin, J. A.
Right arrow Articles by Weksler, B. B.

Arteriosclerosis and Thrombosis, Vol 14, 1021-1031, Copyright © 1994 by American Heart Association


ARTICLES

Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells

JA Rimarachin, JA Jacobson, P Szabo, J Maclouf, C Creminon and BB Weksler
Division of Hematology-Oncology, Cornell University Medical College, New York, NY 10021.

Activation of the gene for inducible cyclooxygenase (cyclooxygenase-2 [Cox-2], prostaglandin endoperoxide synthase) is an early response to injury in vascular smooth muscle cells. We used in vitro and in vivo models to demonstrate that activation of quiescent smooth muscle cells by mitogens leads to a rapid, short-term rise in mRNA for Cox-2, followed by synthesis of new Cox-2 enzyme protein and a marked increase in prostaglandin production that depends on new enzyme synthesis. Moreover, the Cox-2 mRNA response observed in smooth muscle cells differs in both time and degree, depending on the particular mitogenic stimulus. Serum, platelet-derived growth factor, epidermal growth factor, and thrombin are strong inducers of Cox-2 mRNA, whereas acidic and basic fibroblast growth factors and interleukin-1 alpha are weak inducers. In contrast to the transient activation of Cox-2 in vitro after introduction of a mitogenic stimulus, the Cox-2 response after in vivo vascular injury extends over many days and may represent protracted cellular activation. During induction of Cox-2 message and protein, expression of constitutive cyclooxygenase (Cox-1) remains unchanged, however. These data suggest a pathophysiological role for Cox-2 in the early modulation of vascular responses to injury.


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Pape, B. H. Rauch, A. C. Rosenkranz, G. Kaber, and K. Schror
Transcriptional Inhibition of Protease-Activated Receptor-1 Expression by Prostacyclin in Human Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Clement, M. Gueguen, M. Glorian, R. Blaise, M. Andreani, C. Brou, P. Bausero, and I. Limon
Notch3 and IL-1beta exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-{kappa}B drives crosstalk
J. Cell Sci., October 1, 2007; 120(19): 3352 - 3361.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. van den Boom, M. Sarbia, K. von Wnuck Lipinski, P. Mann, J. Meyer-Kirchrath, B.H. Rauch, K. Grabitz, B. Levkau, K. Schror, and J.W. Fischer
Differential Regulation of Hyaluronic Acid Synthase Isoforms in Human Saphenous Vein Smooth Muscle Cells: Possible Implications for Vein Graft Stenosis
Circ. Res., January 6, 2006; 98(1): 36 - 44.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. S. Deeb, H. Shen, C. Gamss, T. Gavrilova, B. D. Summers, R. Kraemer, G. Hao, S. S. Gross, M. Laine, N. Maeda, et al.
Inducible Nitric Oxide Synthase Mediates Prostaglandin H2 Synthase Nitration and Suppresses Eicosanoid Production
Am. J. Pathol., January 1, 2006; 168(1): 349 - 362.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Guo, W. Su, S. Allen, H. Pang, A. Daugherty, E. Smart, and M. C. Gong
COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice
Cardiovasc Res, September 1, 2005; 67(4): 723 - 735.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Ulrich, J. Whitton, J.-H. Yu, J. Sibert, R. Sparks, J. D. Potter, and J. Bigler
PTGS2 (COX-2) -765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 616 - 619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zaric and C. Ruegg
Integrin-mediated Adhesion and Soluble Ligand Binding Stabilize COX-2 Protein Levels in Endothelial Cells by Inducing Expression and Preventing Degradation
J. Biol. Chem., January 14, 2005; 280(2): 1077 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. K. Upmacis, R. S. Deeb, M. J. Resnick, R. Lindenbaum, C. Gamss, D. Mittar, and D. P. Hajjar
Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells
Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1271 - C1280.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Bishop-Bailey, T. Hla, and T. D. Warner
Intimal Smooth Muscle Cells as a Target for Peroxisome Proliferator-Activated Receptor-{gamma} Ligand Therapy
Circ. Res., August 9, 2002; 91(3): 210 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Katsuyama, C. Fan, and C. Yabe-Nishimura
NADPH Oxidase Is Involved in Prostaglandin F2alpha -induced Hypertrophy of Vascular Smooth Muscle Cells. INDUCTION OF NOX1 BY PGF2alpha
J. Biol. Chem., April 12, 2002; 277(16): 13438 - 13442.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Fritsche, S. J. Baek, L. M. King, D. C. Zeldin, T. E. Eling, and D. A. Bell
Functional Characterization of Cyclooxygenase-2 Polymorphisms
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 468 - 476.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
K. Subbaramaiah, P. Bulic, Y. Lin, A. J. Dannenberg, and D. S. Pasco
Development and Use of a Gene Promoter-Based Screen to Identify Novel Inhibitors of Cyclooxygenase-2 Transcription
J Biomol Screen, April 1, 2001; 6(2): 101 - 110.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Praticò, C. Tillmann, Z.-B. Zhang, H. Li, and G. A. FitzGerald
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice
PNAS, March 1, 2001; (2001) 61607398.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
D. Wu, M. G. Hayek, and S. N. Meydani
Vitamin E and Macrophage Cyclooxygenase Regulation in the Aged
J. Nutr., February 1, 2001; 131(2): 382S - 388.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Mietus-Snyder, M. S. Gowri, and R. E. Pitas
Class A Scavenger Receptor Up-regulation in Smooth Muscle Cells by Oxidized Low Density Lipoprotein. ENHANCEMENT BY CALCIUM FLUX AND CONCURRENT CYCLOOXYGENASE-2 UP-REGULATION
J. Biol. Chem., June 2, 2000; 275(23): 17661 - 17670.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Young, K. Mahboubi, A. Haider, I. Li, and N. R. Ferreri
Cyclooxygenase-2 Is Required for Tumor Necrosis Factor-{alpha}- and Angiotensin II-Mediated Proliferation of Vascular Smooth Muscle Cells
Circ. Res., April 28, 2000; 86(8): 906 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E.-C. Garcia-Cohen, J. Marin, L. D. Diez-Picazo, A. B. Baena, M. Salaices, and M. A. Rodriguez-Martinez
Oxidative Stress Induced by tert-Butyl Hydroperoxide Causes Vasoconstriction in the Aorta from Hypertensive and Aged Rats: Role of Cyclooxygenase-2 Isoform
J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 75 - 81.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Z. Yan, K. Subbaramaiah, T. Camilli, F. Zhang, T. Tanabe, T. A. McCaffrey, A. J. Dannenberg, and B. B. Weksler
Benzo[a]pyrene Induces the Transcription of Cyclooxygenase-2 in Vascular Smooth Muscle Cells. EVIDENCE FOR THE INVOLVEMENT OF EXTRACELLULAR SIGNAL-REGULATED KINASE AND NF-kappa B
J. Biol. Chem., February 18, 2000; 275(7): 4949 - 4955.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. Yang, N. Ma, M. J. Szabolcs, J. Zhong, E. Athan, R. R. Sciacca, R. E. Michler, G. D. Anderson, J. F. Wiese, K. M. Leahy, et al.
Upregulation of COX-2 During Cardiac Allograft Rejection
Circulation, February 1, 2000; 101(4): 430 - 438.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Ohnaka, K. Numaguchi, T. Yamakawa, and T. Inagami
Induction of Cyclooxygenase-2 by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells
Hypertension, January 1, 2000; 35(1): 68 - 75.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Bernard, R. Merval, M. Lebret, P. Delerive, I. Dusanter-Fourt, S. Lehoux, C. Creminon, B. Staels, J. Maclouf, and A. Tedgui
Oncostatin M Induces Interleukin-6 and Cyclooxygenase-2 Expression in Human Vascular Smooth Muscle Cells : Synergy With Interleukin-1{beta}
Circ. Res., December 3, 1999; 85(12): 1124 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. R. Wohlfeil and W. B. Campbell
25-Hydroxycholesterol Increases Eicosanoids and Alters Morphology in Cultured Pulmonary Artery Smooth Muscle and Endothelial Cells
Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 2901 - 2908.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Yamamoto, M. Aoyagi, N. Fukai, Y. Matsushima, and K. Yamamoto
Increase in Prostaglandin E2 Production by Interleukin-1{beta} in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease
Circ. Res., November 12, 1999; 85(10): 912 - 918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
U. Schonbeck, G. K. Sukhova, P. Graber, S. Coulter, and P. Libby
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Am. J. Pathol., October 1, 1999; 155(4): 1281 - 1291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Subbaramaiah, N. Altorki, W. J. Chung, J. R. Mestre, A. Sampat, and A. J. Dannenberg
Inhibition of Cyclooxygenase-2 Gene Expression by p53
J. Biol. Chem., April 16, 1999; 274(16): 10911 - 10915.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. S. R. Baker, R. J. C. Hall, T. J. Evans, A. Pomerance, J. Maclouf, C. Creminon, M. H. Yacoub, and J. M. Polak
Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particularly in Macrophages
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 646 - 655.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. F. McAdam, F. Catella-Lawson, I. A. Mardini, S. Kapoor, J. A. Lawson, and G. A. FitzGerald
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
PNAS, January 5, 1999; 96(1): 272 - 277.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Binko, S. Meachem, and H. Majewski
Endothelium removal induces iNOS in rat aorta in organ culture, leading to tissue damage
Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E125 - E134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, S. A. Moore, L. L. Stoll, G. Rich, T. L. Kaduce, N. L. Weintraub, and A. A. Spector
14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2113 - H2121.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. E. Brian Jr, S. A. Moore, F. M. Faraci, and H. A. Kontos
Expression and Vascular Effects of Cyclooxygenase-2 in Brain • Editorial Comment
Stroke, December 1, 1998; 29(12): 2600 - 2606.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Cullen, L. Kelly, S. O. Connor, and D. J. Fitzgerald
Selective Cyclooxygenase-2 Inhibition by Nimesulide in Man
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 578 - 582.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Bishop-Bailey, J. R. Pepper, S. W. Larkin, and J. A. Mitchell
Differential Induction of Cyclooxygenase-2 in Human Arterial and Venous Smooth Muscle : Role of Endogenous Prostanoids
Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1655 - 1661.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger, and W. Seeger
Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1309 - 1314.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Luvara, M. E. Pueyo, M. Philippe, C. Mandet, F. Savoie, D. Henrion, and J.-B. Michel
Chronic Blockade of NO Synthase Activity Induces a Proinflammatory Phenotype in the Arterial Wall : Prevention by Angiotensin II Antagonism
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1408 - 1416.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Osuka, Y. Suzuki, Y. Watanabe, M. Takayasu, J. Yoshida, and D. W. Busija
Inducible Cyclooxygenase Expression in Canine Basilar Artery After Experimental Subarachnoid Hemorrhage • Editorial Comment
Stroke, June 1, 1998; 29(6): 1219 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Vinals, J. Martinez-Gonzalez, J. J. Badimon, and L. Badimon
HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3481 - 3488.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. A. Williams and E. Shacter
Regulation of Macrophage Cytokine Production by Prostaglandin E2. DISTINCT ROLES OF CYCLOOXYGENASE-1 AND -2
J. Biol. Chem., October 10, 1997; 272(41): 25693 - 25699.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Bishop-Bailey, J. R. Pepper, E.-B. Haddad, R. Newton, S. W. Larkin, and J. A. Mitchell
Induction of Cyclooxygenase-2 in Human Saphenous Vein and Internal Mammary Artery
Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1644 - 1648.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Camacho, N. Godessart, R. Antón, M. Garca, and L. Vila
Interleukin-1 Enhances the Ability of Cultured Human Umbilical Vein Endothelial Cells to Oxidize Linoleic Acid
J. Biol. Chem., July 21, 1995; 270(29): 17279 - 17286.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Pratico, C. Tillmann, Z.-B. Zhang, H. Li, and G. A. FitzGerald
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice
PNAS, March 13, 2001; 98(6): 3358 - 3363.
[Abstract] [Full Text] [PDF]